The CDC will distribute 77,000 additional doses of Beyfortus, a respiratory syncytial virus (RSV) drug from Sanofi and AstraZeneca, to deal with shortages and unprecedented demand that has left pediatricians and hospitals struggling to stock the immunization. The doses will be distributed to physicians, hospitals, and through the Vaccines for Children Program.
What’s Next for Healthcare Cybersecurity After a Tumultuous 2024?
Cybersecurity breaches in the healthcare sector are increasing, with ransomware and data exfiltration attacks becoming more frequent. In response, Chief Information Security Officers are putting
